Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Minister's 'Upfront' Approach On Brexit Can Be Blueprint For Wider UK Industry Engagement

Executive Summary

UK junior health minister Lord O'Shaughnessy has impressed the UK medtech industry with his readiness to listen to its concerns and map out potential solutions on Brexit. His inclusive style could usefully be replicated across more medtech themes and by a wider circle of decision-makers, UK manufacturers believe.

You may also be interested in...

UK's ABHI Marks 30 Years Of Championing HealthTech

The UK Association of British HealthTech Industries (ABHI) is marking three decades of supporting local medtech manufacturers and helping develop national and local health-care delivery infrastructures at its annual UK Market Conference in November.

AdvaMed Chair Nadim Yared Talks Challenges, Priorities

The AdvaMed chairman and CVRx CEO spoke to Medtech Insight from the floor of the Pennsylvania Convention Center at this year's MedTech Conference. The discussion focused on the industry's push for a breakthrough reimbursement pathway, the impact of US-China tariff wars and the industry's answer to challenges from grassroots patient groups on device safety, among other challenges and priorities.

UK Innovation, EU Regulation And Digital Transformation Are Top Themes For Medtechs At NHS Expo 2018

NHS England chief Simon Stevens has a habit of stealing headlines in UK health-care circles, and his CAR-T cell therapy approval announcement did the trick at the NHS 2018 Innovation Expo. But medtech innovation schemes and furthering the UK digital agenda emerged as main talking points at the meeting.

Related Content


Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts